WallStreetZenWallStreetZen

NASDAQ: ACHL
Achilles Therapeutics PLC Stock

$1.19-0.05 (-4.03%)
Updated Mar 27, 2024
ACHL Price
$1.19
Fair Value Price
N/A
Market Cap
$48.53M
52 Week Low
$0.74
52 Week High
$1.76
P/E
-0.63x
P/B
0.32x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$75.09M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.14
Operating Cash Flow
-$54M
Beta
0.89
Next Earnings
May 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ACHL Overview

Achilles Therapeutics Plc., a clinical-stagr biopharmaceutical company developing precision T cell therapies to treat various solid tumors (cancer). It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. Achilles was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in 2021/02. The company was founded in 2016 and is headquartered in London, UK.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACHL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACHL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACHL is good value based on its book value relative to its share price (0.32x), compared to the US Biotechnology industry average (6.2x)
P/B vs Industry Valuation
ACHL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ACHL due diligence checks available for Premium users.

Be the first to know about important ACHL news, forecast changes, insider trades & much more!

ACHL News

Valuation

ACHL fair value

Fair Value of ACHL stock based on Discounted Cash Flow (DCF)
Price
$1.19
Fair Value
$4.21
Undervalued by
71.73%
ACHL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACHL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.63x
Industry
14.3x
Market
44.45x

ACHL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.32x
Industry
6.2x
ACHL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACHL's financial health

Profit margin

Revenue
$0.0
Net Income
-$16.7M
Profit Margin
0%
ACHL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$175.3M
Liabilities
$21.9M
Debt to equity
0.14
ACHL's short-term assets ($155.49M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACHL's short-term assets ($155.49M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACHL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$1.0M
Investing
-$63.0k
Financing
$8.0k
ACHL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACHL vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ACHL$48.53M-4.03%-0.63x0.32x
QNCX$48.44M0.00%-1.49x0.58x
CARA$47.50M+19.04%-0.40x0.83x
EFTR$49.59M+4.18%-0.82x-8.56x
MAIA$49.61M+1.64%-1.66x103.89x

Achilles Therapeutics Stock FAQ

What is Achilles Therapeutics's quote symbol?

(NASDAQ: ACHL) Achilles Therapeutics trades on the NASDAQ under the ticker symbol ACHL. Achilles Therapeutics stock quotes can also be displayed as NASDAQ: ACHL.

If you're new to stock investing, here's how to buy Achilles Therapeutics stock.

What is the 52 week high and low for Achilles Therapeutics (NASDAQ: ACHL)?

(NASDAQ: ACHL) Achilles Therapeutics's 52-week high was $1.76, and its 52-week low was $0.74. It is currently -32.39% from its 52-week high and 60.81% from its 52-week low.

How much is Achilles Therapeutics stock worth today?

(NASDAQ: ACHL) Achilles Therapeutics currently has 40,782,948 outstanding shares. With Achilles Therapeutics stock trading at $1.19 per share, the total value of Achilles Therapeutics stock (market capitalization) is $48.53M.

Achilles Therapeutics stock was originally listed at a price of $16.55 in Mar 31, 2021. If you had invested in Achilles Therapeutics stock at $16.55, your return over the last 2 years would have been -92.81%, for an annualized return of -73.19% (not including any dividends or dividend reinvestments).

How much is Achilles Therapeutics's stock price per share?

(NASDAQ: ACHL) Achilles Therapeutics stock price per share is $1.19 today (as of Mar 27, 2024).

What is Achilles Therapeutics's Market Cap?

(NASDAQ: ACHL) Achilles Therapeutics's market cap is $48.53M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Achilles Therapeutics's market cap is calculated by multiplying ACHL's current stock price of $1.19 by ACHL's total outstanding shares of 40,782,948.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.